NASDAQ:TVTX

Travere Therapeutics Stock Insider Trading

etoro logo Buy TVTX
*Your capital is at risk
$55.89
-1.39 (-2.43%)
At Close: Jul 31, 2026

Travere Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -67.53. In total, the insiders bought 700K and sold 260.17K TVTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-67.53
Buy 700K shares
Sell 260.17K shares
73% Buy Activity
Weak Negative Correlation
Sell Signal Medium Confidence
Feb 03, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -67.53.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 15, 2026
Sell
Common Stock
S-Sale
Coughlin Timothy
Director
Director 3 250
Value: $141.3K
May 06, 2026
Sell
Common Stock
S-Sale
Dube Eric M
Chief Executive Officer
CEO / President 22 500
Value: $988.9K
May 06, 2026
Sell
Common Stock
S-Sale
Rote William E.
Chief Research Officer
Officer 2 763
Value: $121.4K
May 06, 2026
Sell
Common Stock
S-Sale
Inrig Jula
Chief Medical Officer
Officer 311
Value: $13.7K
May 06, 2026
Sell
Common Stock
S-Sale
Reed Elizabeth E
Chief Legal Officer And GC
Officer 2 076
Value: $91.2K
May 06, 2026
Sell
Common Stock
S-Sale
Cline Christopher R.
Chief Financial Officer
C-Suite Officer 310
Value: $13.6K
May 05, 2026
Sell
Common Stock
S-Sale
Heerma Peter
Chief Commercial Officer
Officer 2 174
Value: $101.4K
May 05, 2026
Sell
Common Stock
S-Sale
Baynes Roy D.
Director
Director 4 500
Value: $209.9K
May 05, 2026
Buy
Stock option (right to buy)
M-Exempt
Baynes Roy D.
Director
Director 4 500
Value: $82.2K
May 05, 2026
Buy
Common Stock
M-Exempt
Baynes Roy D.
Director
Director 4 500
Value: $82.2K
May 05, 2026
Sell
Common Stock
S-Sale
Cline Christopher R.
Chief Financial Officer
C-Suite Officer 2 181
Value: $101.7K
May 05, 2026
Sell
Common Stock
S-Sale
Inrig Jula
Chief Medical Officer
Officer 2 174
Value: $101.4K
May 05, 2026
Sell
Common Stock
S-Sale
Reed Elizabeth E
Chief Legal Officer And GC
Officer 2 174
Value: $101.4K
May 04, 2026
Buy
Performance-based restricted stock units
M-Exempt
Heerma Peter
Chief Commercial Officer
Officer 4 250
Value: $190.9K
May 04, 2026
Buy
Common Stock
M-Exempt
Dube Eric M
Chief Executive Officer
CEO / President 22 500
Value: $1.01M
May 04, 2026
Buy
Performance-based restricted stock units
A-Award
Dube Eric M
Chief Executive Officer
CEO / President 45 000
Value: $2.02M
May 04, 2026
Buy
Employee stock option (right to buy)
M-Exempt
Inrig Jula
Chief Medical Officer
Officer 20 000
Value: $448.0K
May 04, 2026
Buy
Performance-based restricted stock units
A-Award
Inrig Jula
Chief Medical Officer
Officer 8 500
Value: $381.7K
May 04, 2026
Buy
Performance-based restricted stock units
M-Exempt
Inrig Jula
Chief Medical Officer
Officer 4 250
Value: $190.9K
May 04, 2026
Buy
Common Stock
M-Exempt
Heerma Peter
Chief Commercial Officer
Officer 4 250
Value: $190.9K
May 04, 2026
Buy
Performance-based restricted stock units
A-Award
Heerma Peter
Chief Commercial Officer
Officer 8 500
Value: $381.7K
May 04, 2026
Buy
Common Stock
M-Exempt
Meckler Jeffrey A
Director
Director 8 000
Value: $130.6K
May 04, 2026
Sell
Common Stock
S-Sale
Meckler Jeffrey A
Director
Director 8 000
Value: $360.0K
May 04, 2026
Buy
Stock option (right to buy)
M-Exempt
Meckler Jeffrey A
Director
Director 8 000
Value: $130.6K
May 04, 2026
Buy
Common Stock
M-Exempt
Rote William E.
Chief Research Officer
Officer 4 250
Value: $190.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT TRAVERE THERAPEUTICS, INC.
Travere Therapeutics
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE